What is NDC 0591-2472?

0591-2472 is the product NDC for Tamoxifen Citrate, Tamoxifen citrate 10 mg/1 tablet, listed with the FDA by Actavis Pharma, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tamoxifen Citrate?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tamoxifen Citrate NDC 0591-2472 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-2472Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-2472Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0591-2472-18	0059124721800591247218	180 TABLET in 1 BOTTLE, PLASTIC (0591-2472-18)Marketed from Aug 15, 2011
0591-2472-60	0059124726000591247260	60 TABLET in 1 BOTTLE, PLASTIC (0591-2472-60)Marketed from Aug 15, 2011

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tamoxifen Citrate
Generic name (nonproprietary): tamoxifen citrate
Active ingredients: Tamoxifen citrate — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Actavis Pharma, Inc.NDC labeler code 0591
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070929
Marketing start: Aug 15, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Selective Estrogen Receptor Modulators (Mechanism)
Identifiers: Product ID 0591-2472_20254a14-2e07-4279-8263-c63b6a71d861SPL ID 20254a14-2e07-4279-8263-c63b6a71d861SPL set ID 9b8a4211-120f-4981-ad69-928accb97637RxCUI 198240, 313195UNII 7FRV7310N6
Pharmacologic class: Estrogen Agonist/Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591247218 followed by a unit qualifier and the quantity

Package 00591-2472-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Metastatic Breast Cancer: Tamoxifen citrate tablets, USP are effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen therapy. Adjuvant Treatment of Breast Cancer: Tamoxifen citrate tablets, USP are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some tamoxifen adjuvant studies, most of the…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0591-2472

What is NDC 0591-2472?: 0591-2472 is the product NDC for Tamoxifen Citrate, Tamoxifen citrate 10 mg/1 tablet, listed with the FDA by Actavis Pharma, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tamoxifen Citrate.
What is the active ingredient?: Tamoxifen citrate.
Who is the labeler?: Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tamoxifen Citrate?: 16 other product NDCs are listed under this name. See all Tamoxifen Citrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tamoxifen Citrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	Tablet, Film coatedOral	Dr. Reddy's Labratories Inc.	75907-058	75907-0058-1075907-0058-60
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	Tablet, Film coatedOral	Dr. Reddy's Labratories Inc.	75907-059	75907-0059-1075907-0059-30
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	Tablet, Film coatedOral	Mayne Pharma Commercial LLC	51862-643	51862-0643-1051862-0643-30
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-299	59651-0299-60
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-300	59651-0300-3059651-0300-90
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	Tablet, Film coatedOral	NuCare Pharmaceuticals, Inc.	68071-3990	68071-3990-03
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-2208	72162-2208-06
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-2209	72162-2209-03
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	TabletOral	Actavis Pharma, Inc.	0591-2473	00591-2473-1900591-2473-30
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	TabletOral	A-S Medication Solutions	50090-0485	50090-0485-01

All 17 Tamoxifen Citrate NDCs

Other NDCs under ANDA 070929

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070929
Product	Strength	Form · route	Labeler	Product NDC
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	TabletOral	Actavis Pharma, Inc.	0591-2473
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	TabletOral	A-S Medication Solutions	50090-0485
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	TabletOral	A-S Medication Solutions	50090-0942
Tamoxifen Citrate	Tamoxifen citrate 20 mg/1	TabletOral	Proficient Rx LP	63187-976
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-5254
Tamoxifen Citrate	Tamoxifen citrate 10 mg/1	TabletOral	Bryant Ranch Prepack	72162-2225